Solana Company (HSDT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Completed divestiture of legacy medical device (PoNS) business, realizing a $3.1 million gain and incurring $6.8 million in severance costs, and acquired a profitable Hong Kong regulated trust company for $2 million (half cash, half equity), aligning operations with a digital asset treasury and infrastructure focus.
Launched first institutional validator cluster in Tokyo, securing 500,000 SOL in third-party stake, with revenue recognition expected in Q3 2026.
Expanded team and board with experienced Web3, financial, and digital asset professionals to support growth and execution.
Formed strategic partnerships, including with Jito Foundation and Alatau City, to advance institutional-grade Solana infrastructure and blockchain adoption.
Transitioned to a digital asset treasury model focused on acquiring and holding Solana (SOL), with 86% of assets in SOL as of June 30, 2026.
Financial highlights
Q2 2026 revenue was $2.5 million, up from $43,000 in Q2 2025, driven by staking income; gross profit reached $2.4 million with a gross margin of approximately 97%.
Net loss for Q2 2026 was $30.3 million ($0.38 per share), compared to a $9.8 million loss in Q2 2025, impacted by non-recurring severance and digital asset fair value losses.
For the first half of 2026, net loss was $130.1 million, driven by $121.2 million in realized and unrealized losses on SOL holdings and higher severance costs.
General and administrative expenses rose to $11.1 million in Q2, including $6.8 million in non-recurring severance costs; for the first half, G&A was $16.3 million.
As of June 30, 2026, total assets were $176.1 million, with $170.6 million in SOL holdings and $3.6 million in cash and cash equivalents.
Outlook and guidance
Plans to scale validator infrastructure, expand third-party SOL stake, and convert advisory pipeline into revenue-generating engagements.
Expects general and administrative expenses to normalize as non-core costs are eliminated.
Management expects liquidity to be sufficient for at least the next twelve months, assuming the ability to liquidate digital assets as needed.
Strategy remains focused on generating staking yield above network average and building revenue streams independent of SOL price.
Future results will be heavily dependent on the price and liquidity of SOL, which remains highly volatile.
Latest events from Solana Company
- All director nominees and the auditor appointment were approved without shareholder questions.HSDT
AGM 2026 - Director nominee withdrawn, board size reduced, and new CEO and CFO appointed.HSDT
Proxy filing - Q1 2026 revenue surged on staking, but SOL volatility drove a $99.8M net loss.HSDT
Q1 2026 - Shareholders will vote on director elections, auditor ratification, and board changes at the virtual annual meeting.HSDT
Proxy filing - Annual meeting to elect directors, ratify auditor, and reinforce governance and sustainability.HSDT
Proxy filing - Q4 2025 delivered strong staking rewards, $325.6M net income, and 14% SOL per share growth.HSDT
Q4 2025 - 6.2 million shares registered for resale after warrant exercises; no proceeds to the company.HSDT
Registration Filing - CMS pricing delays hinder access and commercialization, prompting strategic review and regulatory focus.HSDT
Status Update - First third-party reimbursement and Medicare rates expected to drive late-2024 revenue growth.HSDT
Q2 2024